Dorota Danielak
74 Piłsudskiego St
Wroclaw, DS 50020, Poland
Wroclaw, DS 50020, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Successful bioequivalence prediction of immediate-release vortioxetine tablets through prospective virtual crossover and parallel trials.
Journal: Journal of pharmaceutical sciences
Published: October 20, 2025
Comprehensive Evaluation of Push-Pull Osmotic Pump Tablets Using Biopredictive Dissolution Tests in Advanced Modular Platform, MRI Visualizations, and Pharmacokinetic Simulations.
Journal: Molecular pharmaceutics
Published: July 31, 2025
Gastric stress events impact the bioavailability of a poorly soluble weak base dabigatran from pellet-filled capsules: An outcome from pharmacokinetic simulations based on biorelevant dissolution testing, machine learning, and a novel timewise first-order dissolution model.
Journal: International journal of pharmaceutics
Published: January 17, 2025
Compare and PASS - Fast screening of oral dosage forms for bioequivalence probability with the COMPASS software.
Journal: International journal of pharmaceutics
Published: November 26, 2024
More Than a Gut Feeling─A Combination of Physiologically Driven Dissolution and Pharmacokinetic Modeling as a Tool for Understanding Human Gastric Motility.
Journal: Molecular pharmaceutics
Published: July 03, 2024
In Vitro Simulation of the Fasted Gastric Conditions and Their Variability to Elucidate Contrasting Properties of the Marketed Dabigatran Etexilate Pellet-Filled Capsules and Loose Pellets.
Journal: Molecular pharmaceutics
Published: April 03, 2024
Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: February 16, 2024
An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients.
Journal: International journal of pharmaceutics
Published: September 15, 2023
Correction to: PhysioCell®-a Novel, Bio-relevant Dissolution Apparatus: Hydrodynamic Conditions and Factors Influencing the Dissolution Dynamics.
Journal: AAPS PharmSciTech
Published: March 22, 2023
Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - A case study workflow for in vitro-in vivo predictions.
Journal: International journal of pharmaceutics
Published: March 10, 2023
Last Updated: 09/26/2026